View in EDS HTML Full Text PDF Full Text

Monte Carlo‐based dosimetry of proposed bi‐radionuclide (125I and 106Ru/106Rh) eye plaque: A feasibility study.

Saved in:
Bibliographic Details
Title: Monte Carlo‐based dosimetry of proposed bi‐radionuclide (125I and 106Ru/106Rh) eye plaque: A feasibility study.
Authors: Mishra, Subhalaxmi1 (AUTHOR) subha@barc.gov.in, Selvam, T. Palani1,2 (AUTHOR), Sahoo, Sridhar1 (AUTHOR), Saxena, Sanjay Kumar3 (AUTHOR), Kumar, Yogendra3 (AUTHOR), Sapra, Balvinder K.1,2 (AUTHOR)
Source: Medical Physics. Oct2024, Vol. 51 Issue 10, p7561-7573. 13p.
Subjects: Monte Carlo method, Beta rays, Tumor treatment, Radioisotopes, Radioisotope brachytherapy
Abstract: Background: Combining the sharp dose fall off feature of beta‐emitting 106Ru/106Rh radionuclide with larger penetration depth feature of photon‐emitting125I radionuclide in a bi‐radionuclide plaque, prescribed dose to the tumor apex can be delivered while maintaining the tumor dose uniformity and sparing the organs at risk. The potential advantages of bi‐radionuclide plaque could be of interest in context of ocular brachytherapy. Purpose: The aim of the study is to evaluate the dosimetric advantages of a proposed bi‐radionuclide plaque for two different designs, consisting of indigenous 125I seeds and 106Ru/106Rh plaque, using Monte Carlo technique. The study also explores the influence of other commercial 125I seed models and presence or absence of silastic/acrylic seed carrier on the calculated dose distributions. The study further included the calculation of depth dose distributions for the bi‐radionuclide eye plaque for which experimental data are available. Methods: The proposed bi‐radionuclide plaque consists of a 1.2‐mm‐thick silver (Ag) spherical shell with radius of curvature of 12.5 mm, 20 µm‐thick‐106Ru/106Rh encapsulated between 0.2 mm Ag disk, and a 0.1‐mm‐thick Ag window, and water‐equivalent gel containing 12 symmetrically arranged 125I seeds. Two bi‐radionuclide plaque models investigated in the present study are designated as Design I and Design II. In Design I, 125I seeds are placed on the top of the plaque, while in Design II 106Ru/106Rh source is positioned on the top of the plaque. In Monte Carlo calculations, the plaque is positioned in a spherical water phantom of 30 cm diameter. Results: The proposed bi‐radionuclide eye plaque demonstrated superior dose distributions as compared to 125I or 106Ru plaque for tumor thicknesses ranges from 5 to 10 mm. Amongst the designs, dose at a given voxel for Design I is higher as compared to the corresponding voxel dose for Design II. This difference is attributed to the higher degree of attenuation of 125I photons in Ag as compared to beta particles. Influence of different 125I seed models on the normalized lateral dose profiles of Design I (in the absence of carrier) is negligible and within 5% on the central axis depth dose distribution as compared to the corresponding values of the plaque that has indigenous 125I seeds. In the presence of a silastic/acrylic seed carrier, the normalized central axis dose distributions of Design I are smaller by 3%–12% as compared to the corresponding values in the absence of a seed carrier. For the published bi‐radionuclide plaque model, good agreement is observed between the Monte Carlo‐calculated and published measured depth dose distributions for clinically relevant depths. Conclusion: Regardless of the type of 125I seed model utilized and whether silastic/acrylic seed carrier is present or not, Design I bi‐radionuclide plaque offers superior dose distributions in terms of tumor dose uniformity, rapid dose fall off and lesser dose to nearby critical organs at risk over the Design II plaque. This shows that Design I bi‐radionuclide plaque could be a promising alternative to 125I plaque for treatment of tumor sizes in the range 5 to 10 mm. [ABSTRACT FROM AUTHOR]
Copyright of Medical Physics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: egs
DbLabel: Engineering Source
An: 180293766
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Monte Carlo‐based dosimetry of proposed bi‐radionuclide (<superscript>125</superscript>I and <superscript>106</superscript>Ru/<superscript>106</superscript>Rh) eye plaque: A feasibility study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Mishra%2C+Subhalaxmi%22">Mishra, Subhalaxmi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> subha@barc.gov.in</i><br /><searchLink fieldCode="AR" term="%22Selvam%2C+T%2E+Palani%22">Selvam, T. Palani</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sahoo%2C+Sridhar%22">Sahoo, Sridhar</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saxena%2C+Sanjay+Kumar%22">Saxena, Sanjay Kumar</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kumar%2C+Yogendra%22">Kumar, Yogendra</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sapra%2C+Balvinder+K%2E%22">Sapra, Balvinder K.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Medical+Physics%22">Medical Physics</searchLink>. Oct2024, Vol. 51 Issue 10, p7561-7573. 13p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Monte+Carlo+method%22">Monte Carlo method</searchLink><br /><searchLink fieldCode="DE" term="%22Beta+rays%22">Beta rays</searchLink><br /><searchLink fieldCode="DE" term="%22Tumor+treatment%22">Tumor treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Radioisotopes%22">Radioisotopes</searchLink><br /><searchLink fieldCode="DE" term="%22Radioisotope+brachytherapy%22">Radioisotope brachytherapy</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Combining the sharp dose fall off feature of beta‐emitting 106Ru/106Rh radionuclide with larger penetration depth feature of photon‐emitting125I radionuclide in a bi‐radionuclide plaque, prescribed dose to the tumor apex can be delivered while maintaining the tumor dose uniformity and sparing the organs at risk. The potential advantages of bi‐radionuclide plaque could be of interest in context of ocular brachytherapy. Purpose: The aim of the study is to evaluate the dosimetric advantages of a proposed bi‐radionuclide plaque for two different designs, consisting of indigenous 125I seeds and 106Ru/106Rh plaque, using Monte Carlo technique. The study also explores the influence of other commercial 125I seed models and presence or absence of silastic/acrylic seed carrier on the calculated dose distributions. The study further included the calculation of depth dose distributions for the bi‐radionuclide eye plaque for which experimental data are available. Methods: The proposed bi‐radionuclide plaque consists of a 1.2‐mm‐thick silver (Ag) spherical shell with radius of curvature of 12.5 mm, 20 µm‐thick‐106Ru/106Rh encapsulated between 0.2 mm Ag disk, and a 0.1‐mm‐thick Ag window, and water‐equivalent gel containing 12 symmetrically arranged 125I seeds. Two bi‐radionuclide plaque models investigated in the present study are designated as Design I and Design II. In Design I, 125I seeds are placed on the top of the plaque, while in Design II 106Ru/106Rh source is positioned on the top of the plaque. In Monte Carlo calculations, the plaque is positioned in a spherical water phantom of 30 cm diameter. Results: The proposed bi‐radionuclide eye plaque demonstrated superior dose distributions as compared to 125I or 106Ru plaque for tumor thicknesses ranges from 5 to 10 mm. Amongst the designs, dose at a given voxel for Design I is higher as compared to the corresponding voxel dose for Design II. This difference is attributed to the higher degree of attenuation of 125I photons in Ag as compared to beta particles. Influence of different 125I seed models on the normalized lateral dose profiles of Design I (in the absence of carrier) is negligible and within 5% on the central axis depth dose distribution as compared to the corresponding values of the plaque that has indigenous 125I seeds. In the presence of a silastic/acrylic seed carrier, the normalized central axis dose distributions of Design I are smaller by 3%–12% as compared to the corresponding values in the absence of a seed carrier. For the published bi‐radionuclide plaque model, good agreement is observed between the Monte Carlo‐calculated and published measured depth dose distributions for clinically relevant depths. Conclusion: Regardless of the type of 125I seed model utilized and whether silastic/acrylic seed carrier is present or not, Design I bi‐radionuclide plaque offers superior dose distributions in terms of tumor dose uniformity, rapid dose fall off and lesser dose to nearby critical organs at risk over the Design II plaque. This shows that Design I bi‐radionuclide plaque could be a promising alternative to 125I plaque for treatment of tumor sizes in the range 5 to 10 mm. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Medical Physics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=180293766
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/mp.17257
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 7561
    Subjects:
      – SubjectFull: Monte Carlo method
        Type: general
      – SubjectFull: Beta rays
        Type: general
      – SubjectFull: Tumor treatment
        Type: general
      – SubjectFull: Radioisotopes
        Type: general
      – SubjectFull: Radioisotope brachytherapy
        Type: general
    Titles:
      – TitleFull: Monte Carlo‐based dosimetry of proposed bi‐radionuclide (125I and 106Ru/106Rh) eye plaque: A feasibility study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mishra, Subhalaxmi
      – PersonEntity:
          Name:
            NameFull: Selvam, T. Palani
      – PersonEntity:
          Name:
            NameFull: Sahoo, Sridhar
      – PersonEntity:
          Name:
            NameFull: Saxena, Sanjay Kumar
      – PersonEntity:
          Name:
            NameFull: Kumar, Yogendra
      – PersonEntity:
          Name:
            NameFull: Sapra, Balvinder K.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 00942405
          Numbering:
            – Type: volume
              Value: 51
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Medical Physics
              Type: main
ResultId 1